• Latest Posts

Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M

Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes

Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval

It’s World Diabetes Day! But What is Biotech Doing to Fight the Disease?

More News! 18 Aug 2017

Novo Nordisk’s New Type 2 Diabetes Drug Outperforms Eli Lilly’s

French Biotech Strikes Deal with Novo Nordisk for New Cancer Drug

In Depth 21 Mar 2017

Rethinking Profits: Can a Socially Conscious Model work in Biotech?

Interview 27 Feb 2017

Meet the Woman developing the Next Generation of Insulin

Top 5 Biologicals from European Biopharma to Launch in 2017

Novo Nordisk will open a €135M Diabetes R&D Center at Oxford University